NCT04611061View on ClinicalTrials.gov

Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

December 13, 2017

Study Completion Date

June 14, 2018

Conditions
Acute Upper Respiratory Tract InfectionInfluenzaRespiratory Viral Infection
Interventions
DRUG

Kagocel

Investigators could prescribe other drugs in frame of routine clinical practice

DRUG

No one

Investigators don't prescribe any antiviral drugs in frame of routine clinical practice

Trial Locations (1)

249040

Obninsk institute for nuclear power engineering (OINPE), Obninsk

All Listed Sponsors
lead

Nearmedic Plus LLC

INDUSTRY

NCT04611061 - Kagocel® for the Prevention of ARVI and Influenza in Adults Health Care Workers | Biotech Hunter | Biotech Hunter